Bayhill Therapeutics and the Juvenile Diabetes Research Foundation Announce Research Collaboration for the Clinical Development of a Novel Immunotherapeutic DNA Vaccine for Type 1 Diabetes

Download Formats

• Thumbnail
  JPEG, 72x26, 2.3 KB
• Preview
  JPEG, 144x53, 6.0 KB
• Low Resolution
  JPEG, 300x112, 17.2 KB
• High Resolution
  JPEG, 1034x387, 87.7 KB

Share This Graphic